TransMedics Group, Inc.
TMDX
$121.34
-$0.77-0.63%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 18.02% | 11.83% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 18.02% | 11.83% | |||
| Cost of Revenue | 11.49% | 3.54% | |||
| Gross Profit | 22.52% | 18.35% | |||
| SG&A Expenses | -6.99% | 9.96% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.76% | 7.77% | |||
| Operating Income | 217.48% | 120.34% | |||
| Income Before Tax | 281.69% | 64.64% | |||
| Income Tax Expenses | 653.03% | 355.17% | |||
| Earnings from Continuing Operations | 274.54% | 62.64% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 274.54% | 62.64% | |||
| EBIT | 217.48% | 120.34% | |||
| EBITDA | 134.43% | 57.41% | |||
| EPS Basic | 273.15% | 61.86% | |||
| Normalized Basic EPS | 280.31% | 63.93% | |||
| EPS Diluted | 251.10% | 66.67% | |||
| Normalized Diluted EPS | 236.58% | 66.80% | |||
| Average Basic Shares Outstanding | 0.38% | 0.45% | |||
| Average Diluted Shares Outstanding | 13.36% | -1.33% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||